Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer
一项随机对照试验比较了一线酪氨酸激酶抑制剂(TKI)与间断TKI联合化疗治疗EGFR突变型非小细胞肺癌的疗效
期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00239-2022
Gijtenbeek, Rolof G P; van der Noort, Vincent; Aerts, Joachim G J V; Staal-van den Brekel, Jeske A; Smit, Egbert F; Krouwels, Frans H; Wilschut, Frank A; Hiltermann, T Jeroen N; Timens, Wim; Schuuring, Ed; Janssen, Joost D J; Goosens, Martijn; van den Berg, Paul M; de Langen, A Joop; Stigt, Jos A; van den Borne, Ben E E M; Groen, Harry J M; van Geffen, Wouter H; van der Wekken, Anthonie J